GGrantIndex
← Leaderboards

Jerry A Schneider

University Of California San Diego

$14,686
Attributed
$14,686
Total exposure
6
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $6.1K · FY200509
$10K$7.5K$5K$2.5K$0
'05
'06
'07
'08
'09

Funding mix

By agency

NIH$14,686 · 6

By mechanism

M01$14,686 · 6

Top collaborators

No co-investigators on record.

Most similar at University Of California San Diego

Same institution · by research overlap

Others in their field

Top investigators on “Clinical Research

Research focus

Clinical ResearchHuman SubjectCystinosisDosageDrug Screening /EvaluationCystineLeukocytesHuman Therapy EvaluationCysteaminePatient /Disease RegistryLongitudinal Human StudyBlood ChemistryOutcomes ResearchOral AdministrationDrug Adverse EffectMetabolism Disorder ChemotherapyClearance RateWhole BloodBlood SpecimenComputer Retrieval Of Information On Scientific Projects DatabaseFundingGrantInstitutionResearch Personnel

Grant awards (32)

DO LEUKOCYTES NEED TO BE SEPARATED FROM WHOLE BLOOD FOR CYSTINE LEVELS$1,699
M01 · FY2009 · RR · contact PI
DO LEUKOCYTES NEED TO BE SEPARATED FROM WHOLE BLOOD FOR CYSTINE LEVELS$457
M01 · FY2008 · RR · contact PI
DIAGNOSIS AND MONITORING OF PATIENTS WITH CYSTINOSIS$525
M01 · FY2006 · RR · contact PI
DIAGNOSIS AND MONITORING OF PATIENTS WITH CYSTINOSIS$6,105
M01 · FY2005 · RR
Diagnosis and Monitoring of Patients with Cystinosis$5,900
M01 · FY2004 · RR
DATABANK FOR MONITORING PATIENTS WITH CYSTINOSIS$0
M01 · FY2002 · RR
DATABANK FOR MONITORING PATIENTS WITH CYSTINOSIS$0
M01 · FY2002 · RR
DATABANK FOR MONITORING PATIENTS WITH CYSTINOSIS$0
M01 · FY2002 · RR
DATABANK FOR MONITORING PATIENTS WITH CYSTINOSIS$0
M01 · FY2002 · RR
ESTIMATION OF ORAL CYSTEAMINE BITARTRATE AT STEADY STATE IN CYSTINOSIS$0
M01 · FY2002 · RR
ESTIMATION OF ORAL CYSTEAMINE BITARTRATE AT STEADY STATE IN CYSTINOSIS$0
M01 · FY2002 · RR
ESTIMATION OF ORAL CYSTEAMINE BITARTRATE AT STEADY STATE IN CYSTINOSIS$0
M01 · FY2002 · RR
ESTIMATION OF ORAL CYSTEAMINE BITARTRATE AT STEADY STATE IN CYSTINOSIS$0
M01 · FY2002 · RR
CYSTEAMINE TO TREAT CORNEAL CYSTINE CRYSTAL ACCUMULATION$0
M01 · FY2002 · RR
CYSTEAMINE TO TREAT CORNEAL CYSTINE CRYSTAL ACCUMULATION$0
M01 · FY2002 · RR
CYSTEAMINE TO TREAT CORNEAL CYSTINE CRYSTAL ACCUMULATION$0
M01 · FY2002 · RR
CYSTEAMINE TO TREAT CORNEAL CYSTINE CRYSTAL ACCUMULATION$0
M01 · FY2002 · RR
ESTIMATION OF ORAL CYSTEAMINE BITARTRATE AT STEADY STATE IN CYSTINOSIS$0
M01 · FY2001 · RR
ESTIMATION OF ORAL CYSTEAMINE BITARTRATE AT STEADY STATE IN CYSTINOSIS$0
M01 · FY2001 · RR
CYSTEAMINE TO TREAT CORNEAL CYSTINE CRYSTAL ACCUMULATION$0
M01 · FY2001 · RR
CYSTEAMINE TO TREAT CORNEAL CYSTINE CRYSTAL ACCUMULATION$0
M01 · FY2001 · RR
DATABANK FOR MONITORING PATIENTS WITH CYSTINOSIS$0
M01 · FY2001 · RR
DATABANK FOR MONITORING PATIENTS WITH CYSTINOSIS$0
M01 · FY2001 · RR
CYSTEAMINE TO TREAT CORNEAL CYSTINE CRYSTAL ACCUMULATION$0
M01 · FY2000 · RR
DATABANK FOR MONITORING PATIENTS WITH CYSTINOSIS$0
M01 · FY2000 · RR
ESTIMATION OF ORAL CYSTEAMINE BITARTRATE AT STEADY STATE IN CYSTINOSIS$0
M01 · FY2000 · RR
DATABANK FOR MONITORING PATIENTS WITH CYSTINOSIS$0
M01 · FY2000 · RR
ESTIMATION OF ORAL CYSTEAMINE BITARTRATE AT STEADY STATE IN CYSTINOSIS$0
M01 · FY2000 · RR
ESTIMATION OF ORAL CYSTEAMINE BITARTRATE AT STEADY STATE IN CYSTINOSIS$0
M01 · FY2000 · RR
DATABANK FOR MONITORING PATIENTS WITH CYSTINOSIS$0
M01 · FY2000 · RR
CYSTEAMINE TO TREAT CORNEAL CYSTINE CRYSTAL ACCUMULATION$0
M01 · FY2000 · RR
CYSTEAMINE TO TREAT CORNEAL CYSTINE CRYSTAL ACCUMULATION$0
M01 · FY2000 · RR